Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,301 | -11,000 | N/A | -23,042 | -11,524 |
| Depreciation Amortization | 9,826 | 5,102 | N/A | 13,800 | 9,030 |
| Income taxes - deferred | -7,070 | -4,349 | N/A | -7,881 | -2,624 |
| Accounts receivable | 9,559 | 11,144 | N/A | 27 | -397 |
| Accounts payable and accrued liabilities | 10,539 | 917 | N/A | 11,791 | -6,105 |
| Other Working Capital | 20,320 | 20,326 | N/A | -1,165 | -12,218 |
| Other Operating Activity | -417 | -5,119 | 0 | 2,132 | 8,916 |
| Operating Cash Flow | $18,456 | $17,021 | $N/A | $-4,338 | $-14,922 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 5,478 | 232 | N/A | -19,686 | -16,000 |
| Other Investing Activity | 0 | 0 | 0 | 364 | 364 |
| Investing Cash Flow | $5,478 | $232 | $N/A | $-19,322 | $-15,636 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 24,000 | 11,000 | N/A | 84,400 | 62,900 |
| Debt Issued | N/A | N/A | N/A | 27,500 | 27,500 |
| Debt Repayment | -20,062 | -8,030 | N/A | -8,094 | -5,062 |
| Common Stock Issued | N/A | N/A | N/A | 30 | 30 |
| Other Financing Activity | -25,934 | -19,994 | 0 | -78,841 | -54,296 |
| Financing Cash Flow | $-21,996 | $-17,024 | $N/A | $24,995 | $31,072 |
| Beginning Cash Position | 553 | 553 | N/A | 1,465 | 1,465 |
| End Cash Position | 2,491 | 782 | N/A | 2,800 | 1,979 |
| Net Cash Flow | $1,938 | $229 | $N/A | $1,335 | $514 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,456 | 17,021 | N/A | -4,338 | -14,922 |
| Capital Expenditure | -7,407 | -4,623 | N/A | -22,118 | -16,029 |
| Free Cash Flow | 11,049 | 12,398 | 0 | -26,456 | -30,951 |